These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26055177)

  • 1. Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles.
    Blanco VM; Latif T; Chu Z; Qi X
    Transl Oncol; 2015 Jun; 8(3):196-203. PubMed ID: 26055177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer.
    Davis HW; Kaynak A; Vallabhapurapu SD; Qi X
    World J Gastrointest Oncol; 2021 Jun; 13(6):550-559. PubMed ID: 34163572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein.
    Qi X; Chu Z; Mahller YY; Stringer KF; Witte DP; Cripe TP
    Clin Cancer Res; 2009 Sep; 15(18):5840-51. PubMed ID: 19737950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting and cytotoxicity of SapC-DOPS nanovesicles in pancreatic cancer.
    Chu Z; Abu-Baker S; Palascak MB; Ahmad SA; Franco RS; Qi X
    PLoS One; 2013; 8(10):e75507. PubMed ID: 24124494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer: current standards, working towards a new therapeutic approach.
    Olowokure O; Qi X
    Expert Rev Anticancer Ther; 2014 May; 14(5):495-7. PubMed ID: 24621210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of advanced pancreatic cancer.
    Li J; Podoltsev N; Saif MW
    Expert Rev Clin Pharmacol; 2009 Sep; 2(5):527-41. PubMed ID: 22112226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review.
    Li CH; Karantza V; Aktan G; Lala M
    Breast Cancer Res; 2019 Dec; 21(1):143. PubMed ID: 31842957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approaches to target pancreatic cancer.
    Porzner M; Seufferlein T
    Curr Cancer Drug Targets; 2011 Jul; 11(6):698-713. PubMed ID: 21599630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cancer cells using SapC-DOPS nanovesicles.
    Davis HW; Hussain N; Qi X
    Mol Cancer; 2016 May; 15(1):33. PubMed ID: 27160923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of novel therapeutic options for pancreatic cancer.
    Saluja AK; Dudeja V; Banerjee S
    Curr Opin Gastroenterol; 2016 Sep; 32(5):401-407. PubMed ID: 27454027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy.
    Kaynak A; Davis HW; Kogan AB; Lee JH; Narmoneva DA; Qi X
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of systemic therapy for advanced pancreatic cancer.
    El-Rayes BF; Philip PA
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.
    Sclafani F; Morano F; Cunningham D; Baratelli C; Kalaitzaki E; Watkins D; Starling N; Chau I; Rao S
    Oncologist; 2017 Apr; 22(4):402-408. PubMed ID: 28209745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment of advanced pancreatic cancer using novel vaccine and traditional therapies.
    Matsui H; Hazama S; Shindo Y; Nagano H
    Expert Rev Anticancer Ther; 2018 Dec; 18(12):1205-1217. PubMed ID: 30295097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinational therapy: new hope for pancreatic cancer?
    Shi S; Yao W; Xu J; Long J; Liu C; Yu X
    Cancer Lett; 2012 Apr; 317(2):127-35. PubMed ID: 22138436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review.
    Sheahan AV; Biankin AV; Parish CR; Khachigian LM
    Oncotarget; 2018 Apr; 9(30):21613-21627. PubMed ID: 29765563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer.
    Regel I; Mayerle J; Mahajan UM
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32326341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.